Loading...

Basel Medical Group Ltd Ordinary Shares

BMGL•NASDAQ
Healthcare
Medical - Healthcare Plans
$2.97
$-0.65(-17.96%)

Basel Medical Group Ltd Ordinary Shares (BMGL) Stock Overview

Explore Basel Medical Group Ltd Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.6/100

Key Financials

Market Cap55.4M
P/E Ratio0.00
EPS (TTM)$0.01
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Week$2.70
1 Month$2.03
3 Months$3.20
1 Year TargetN/A

BMGL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Basel Medical Group Ltd Ordinary Shares (BMGL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 55.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

52.61RSI (14)
-0.23MACD
26.73ADX
Stats data is not available for BMGLStats details for BMGL are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BMGLAnalyst Recommendations details for BMGL are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.

CEO

Yen Feng Chhoa

Employees

32

Headquarters

600 North Bridge Road, Singapore

Founded

2025

Frequently Asked Questions

;